1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 23 NOVEMBER 2015

Cancer Drug News 23 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Pfizer Laying Strong Foundations For Long-Term Oncology Growth
Industry Brief - Kadcyla Price Remains Too High For NICE
Industry Brief - Kyprolis Gains EU Approval For Combination Use In Relapsed MM
Industry Trend Analysis - Crowded MM Market Will Provide Challenge For Ninlaro
Industry Brief - FDA Grants ODD To Marizomib In Malignant Glioma
Industry Brief - ZAI Lab/Hanmi Sign Chinese Licensing Deal To Develop EGFr-Targeted LC Therapy
Industry Brief - Xalkori Significantly Prolongs PFS In East Asian Phase III Study For ALK-Positive NSCLC
Industry Trend Analysis - Clovis Rociletinib Slip Solidifies AstraZeneca's Position
Industry Trend Analysis - CDx Evolving With Increased Precision Medicine Focus
Industry Brief - FDA Accepts For Priority Review Opdivo sBLA In RCC
Industry Brief - Morphotek Signs Radioimmunotherapy Pact With University Of Gothenburg
Industry Brief - Chugai Receives Japanese Approval For Additional Xeloda Indication
Industry Brief - Threshold/Merck KGaA Enter Evofosfamide Co-Promotion Agreement
Industry Brief - Tafinlar+Mekinist Receives Regular FDA Approval For MM
Industry Brief - FDA Grants Breakthrough Therapy Designation To Avelumab For MCC
Industry Brief - Sandoz' Third Biosimilar Application Accepted By The FDA
Industry Brief - Cancer Conferences - February 2016

Table Of Contents

Cancer Drug News 23 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.